SCHEMBL30833508

SCHEMBL30833508

Cc1cc(S(=O)(=O)C(F)(F)C2CCCCN2C(=O)OC(C)(C)C)n(C)n1

nearest known ligand 0.36

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
WNT3 P56703 2/20 0.36
SFRP1 Q8N474 2/20 0.36
LMNA P02545 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
STS P08842 1/20 0.34
CPT1A P50416 3/20 0.33
CPT2 P23786 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833490 0.88 WNT3 (0.35) WNT3SFRP1LMNANPSR1MEN1
SCHEMBL30833506 0.81 SFRP1 (0.39) WNT3SFRP1LMNANPSR1MEN1
SCHEMBL17948987 0.81 STS (0.44) MEN1KMT2ASTS
SCHEMBL30833399 0.80 MEN1 (0.38) WNT3SFRP1LMNANPSR1MEN1
SCHEMBL30833510 0.79 PDE8B (0.40) LMNANPSR1CPT1ACPT2NPC1
SCHEMBL30833437 0.76 RORC (0.37) WNT3SFRP1LMNA
SCHEMBL29082018 0.75 ALDH1A1 (0.42) LMNANPSR1MEN1KMT2AL3MBTL1
SCHEMBL30833425 0.75 RIPK1 (0.45) WNT3SFRP1MEN1KMT2ANR1H2
SCHEMBL30833463 0.73 MEN1 (0.43) WNT3SFRP1MEN1KMT2ANR1H2
SCHEMBL30833487 0.73 SFRP1 (0.40) WNT3SFRP1MEN1KMT2ANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118164961-A 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-06-11 CN disclosed
CN-111393414-B 4-Methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2024-05-07 CN disclosed